Lyme Autoimmune Panel

The Lyme Autoimmune Panel is a blood test that measures 11 key markers to help detect, assess, and monitor Lyme disease and related immune responses.

This advanced panel is designed to evaluate the body’s autoimmune reaction to Borrelia burgdorferi, the bacteria responsible for Lyme disease. By analyzing a range of specific antibodies and immune markers, this test provides critical insight into both acute and chronic stages of Lyme, as well as possible autoimmune complications that can result from long-term infection.

Unlike standard Lyme tests, this panel offers a deeper look into how the immune system is reacting—especially in cases where symptoms persist but traditional testing falls short. It is a valuable tool for individuals with ongoing fatigue, joint pain, neurological symptoms, or other unexplained health issues that may be linked to Lyme or tick-borne illnesses.

With just one blood draw, the Lyme Autoimmune Panel offers a comprehensive view of immune activity and supports more informed treatment decisions, giving patients and practitioners greater clarity in complex health situations.